4//SEC Filing
Bellon Christine 4
Accession 0000950170-25-050859
CIK 0001745999other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 9:53 PM ET
Size
5.4 KB
Accession
0000950170-25-050859
Insider Transaction Report
Form 4
Bellon Christine
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-04-01$18.35/sh−5,674$104,122→ 117,294 total
Footnotes (2)
- [F1]shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan on each of March 31, 2021, March 31, 2022, March 31, 2023 and March 31, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.38, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Beam Therapeutics Inc.
CIK 0001745999
Entity typeother
Related Parties
1- filerCIK 0001963878
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 9:53 PM ET
- Size
- 5.4 KB